Tilaknagar Industries Q4FY26 net revenue rises 148% to INR 949 crore
Tilaknagar Industries Ltd. reported a 148% year-on-year increase in net revenue to INR 949 crore for Q4FY26, driven by the inclusion of the Imperial Blue business division. The company achieved an overall volume of 8 million cases during the quarter, with Imperial Blue contributing 4.6 million cases. EBITDA for the quarter stood at INR 155 crore, reflecting a 97% growth with a margin of 16.3%. For the full year FY26, revenues grew by 70% to reach INR 2,346 crore, while EBITDA increased by 64% to INR 419 crore.

*this image is generated using AI for illustrative purposes only.
Tilaknagar Industries Ltd. reported a 148% year-on-year increase in net revenue to INR 949 crore for Q4FY26, driven by the inclusion of the Imperial Blue business division. The company achieved an overall volume of 8 million cases during the quarter, with Imperial Blue contributing 4.6 million cases. EBITDA for the quarter stood at INR 155 crore, reflecting a 97% growth with a margin of 16.3%. For the full year FY26, revenues grew by 70% to reach INR 2,346 crore, while EBITDA increased by 64% to INR 419 crore.
The company disclosed the transcript of its earnings conference call held on May 30, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Amit Dahanukar, Chairman and Managing Director, highlighted that Mansion House Brandy crossed the volume benchmark of 10 million cases in FY26, cementing its position as India's largest Prestige and Above (P&A) brandy.
Financial Performance
Management noted a change in presentation regarding revenue recognition, where selling expenses are now deducted from gross revenue rather than shown under other expenses. This change negatively impacts reported revenue and gross margins but positively impacts EBITDA and PAT margins. Net Sales Realisation (NSR) increased by 5.4% to INR 1,177 per case in Q4FY26 from INR 1,116 per case in Q4FY25.
| Metric | Q4FY26 | YoY Growth |
|---|---|---|
| Net Revenue | INR 949 crore | 148% |
| EBITDA | INR 155 crore | 97% |
| EBITDA Margin | 16.3% | - |
| Overall Volume | 8 million cases | 135% |
| FY26 Revenue | INR 2,346 crore | 70% |
| FY26 EBITDA | INR 419 crore | 64% |
Operational Highlights and Guidance
The company received government approval to expand capacity at its Prag facility in Andhra Pradesh from 6 lakh cases per annum to 36 lakh cases per annum, entailing an investment of INR 59 crore. This expansion is expected to generate savings of INR 10 crore per annum in bottling costs. On the integration front, 75% of the Imperial Blue business has exited the Third-Party Supply and Manufacturing Agreement (TSMA), with the remaining transition expected by March 2027.
For FY27, the company expects high-single digit to low-double digit volume growth for the combined business. It targets consolidated EBITDA margins of 16%-18% over the next 24 to 36 months. The Board of Directors has recommended a dividend of INR 1 per share for FY25-'26. As on March 31, 2026, gross debt stood at INR 2,295 crore and net debt at INR 1,911 crore.
Historical Stock Returns for Tilaknagar Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.81% | -6.53% | -10.11% | -9.51% | +16.70% | +1,023.01% |
How will Tilaknagar Industries manage its net debt of INR 1,911 crore, and what is the timeline for meaningful deleveraging given its current EBITDA trajectory?
With the remaining 25% of Imperial Blue still under the TSMA agreement, what operational or regulatory risks could delay the full transition beyond the March 2027 target?
Can Mansion House Brandy sustain its position as India's largest P&A brandy amid intensifying competition from multinational spirits companies expanding in the Indian market?


































